These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18192895)

  • 1. Taq1A polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers.
    Kim E; Kwon JS; Shin YW; Lee JS; Kang WJ; Jo HJ; Lee JM; Yu KS; Kang DH; Cho JY; Jang IJ; Shin SG
    Pharmacogenet Genomics; 2008 Feb; 18(2):91-7. PubMed ID: 18192895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
    Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
    J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.
    Kwon JS; Kim E; Kang DH; Choi JS; Yu KS; Jang IJ; Shin SG;
    Eur Neuropsychopharmacol; 2008 Dec; 18(12):897-907. PubMed ID: 18786813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study.
    Kim E; Yu KS; Cho JY; Shin YW; Yoo SY; Kim YY; Jang IJ; Shin SG; Kwon JS
    Hum Psychopharmacol; 2006 Dec; 21(8):519-28. PubMed ID: 16981227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia.
    Nagai G; Mihara K; Nakamura A; Suzuki T; Nemoto K; Kagawa S; Ohta I; Arakaki H; Kondo T
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):518-24. PubMed ID: 23066770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine.
    Aklillu E; Kalow W; Endrenyi L; Harper P; Miura J; Ozdemir V
    Pharmacogenet Genomics; 2007 Nov; 17(11):989-93. PubMed ID: 18075468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.
    Shen YC; Chen SF; Chen CH; Lin CC; Chen SJ; Chen YJ; Luu SU
    J Psychiatr Res; 2009 Mar; 43(6):600-6. PubMed ID: 18926547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).
    Kurylev AA; Brodyansky VM; Andreev BV; Kibitov AO; Limankin OV; Mosolov SN
    Psychiatr Danub; 2018 Jun; 30(2):157-163. PubMed ID: 29930225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.
    Tan EK; Tan Y; Chai A; Tan C; Shen H; Lum SY; Fook-Cheong SM; Teoh ML; Yih Y; Wong MC; Zhao Y
    Mov Disord; 2003 May; 18(5):593-5. PubMed ID: 12722176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole.
    Kim E; Howes OD; Turkheimer FE; Kim BH; Jeong JM; Kim JW; Lee JS; Jang IJ; Shin SG; Kapur S; Kwon JS
    Psychopharmacology (Berl); 2013 May; 227(2):221-9. PubMed ID: 23271192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of dopamine D2 receptor (DRD2) gene polymorphisms in cannabinoid addicts.
    Nacak M; Isir AB; Balci SO; Pehlivan S; Benlier N; Aynacioglu S
    J Forensic Sci; 2012 Nov; 57(6):1621-4. PubMed ID: 22536882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes.
    Schellekens AF; Franke B; Ellenbroek B; Cools A; de Jong CA; Buitelaar JK; Verkes RJ
    Arch Gen Psychiatry; 2012 Apr; 69(4):339-48. PubMed ID: 22474103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population.
    Behravan J; Hemayatkar M; Toufani H; Abdollahian E
    Arch Iran Med; 2008 May; 11(3):252-6. PubMed ID: 18426314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine gene predicts the brain's response to dopaminergic drug.
    Cohen MX; Krohn-Grimberghe A; Elger CE; Weber B
    Eur J Neurosci; 2007 Dec; 26(12):3652-60. PubMed ID: 18088284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor D2 gene Taq1A (C32806T) polymorphism modifies the relationship between birth weight and educational attainment in adulthood: 21-year follow-up of the Cardiovascular Risk in Young Finns study.
    Keltikangas-Järvinen L; Elovainio M; Kivimäki M; Raitakari OT; Viikari JS; Lehtimäki T
    Pediatrics; 2007 Oct; 120(4):756-61. PubMed ID: 17908762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double dissociation of dopamine genes and timing in humans.
    Wiener M; Lohoff FW; Coslett HB
    J Cogn Neurosci; 2011 Oct; 23(10):2811-21. PubMed ID: 21261454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine-induced changes in neural network patterns supporting aversive conditioning.
    Diaconescu AO; Menon M; Jensen J; Kapur S; McIntosh AR
    Brain Res; 2010 Feb; 1313():143-61. PubMed ID: 19961836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
    Leite JV; Guimarães FS; Moreira FA
    Eur J Pharmacol; 2008 Jan; 578(2-3):222-7. PubMed ID: 18021764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.